89bio Inc 's ROA from the second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is 89bio Inc 's ROA in the second quarter of 2025?
89bio Inc recorded a cumulative net loss of $-450 million during 12 months ending in the second quarter of 2025, resulting in a negative return on assets (ROA) of -80.93%.

However, within the Healthcare sector 727 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2025 from 4351 to 4353.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Total Assets Change	3.67 %	18.66 %	-19.76 %	-0.41 %	18.2 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-450	-387	-367	-289	-175
Return On Assets (TTM)	-80.93 %	-70.18 %	-70.05 %	-52.21 %	-31.52 %
ETNB's Total Ranking	# 4353	# 4351	# 5012	# 4277	# 3975
Total Assets (TTM) in million	603	685	478	458	582
Seq. Total Assets Change	-11.9 %	43.17 %	4.42 %	-21.29 %	0.83 %
Seq. Net Income Change	-	-	-	-	-

ETNB's 5 Years Annual ROA >> Back to ETNB Management Effectiveness >> Compare ETNB ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 335
Sector	# 728
Overall	# 4297

Return On Assets Statistics
High	Average	Low
32.09 %	-42.88 %	-80.92 %
(Jun 30 2020)		(Jun 30 2025)

Financial Statements
89bio Inc 's Assets	$ 603 million	ETNB's Balance sheet
89bio Inc 's Income	$ -112 million	Quarterly ETNB's Income Statement
ETNB's Income by Division		See ETNB's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020
Y / Y Total Assets Change	-19.76 %	202.95 %	21.18 %	-23.05 %	120.9 %
Total Assets in million	478	596	197	162	211
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-367	-142	-102	-90	-49
Annual Return On Assets	-76.72 %	-23.85 %	-51.84 %	-55.49 %	-23.45 %

ETNB's 5 Years Annual ROA >> Back to ETNB Management Effectiveness >> Compare ETNB ROA to its Competitors

More Return On Assets Ratios
ETNB's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ETNB's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ETNB's Competitors
Subscribers only: Roa for 89bio Inc 's Suppliers
Subscribers only: Return On Assets for ETNB's Customers

You may also want to know
ETNB's Roi	ETNB's Inventory Turnover Ratio	ETNB's Growth Rates	ETNB's Dividend Comparisons
	ETNB's Profitability Ratios	ETNB's Asset Turnover Ratio	ETNB's Dividend Growth
ETNB's Roe	ETNB's Valuation Ratios	ETNB's Financial Strength Ratios	ETNB's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:11:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.